Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
341
-
Total 13F shares, excl. options
-
136M
-
Shares change
-
+18.4M
-
Total reported value, excl. options
-
$7.34B
-
Value change
-
+$905M
-
Put/Call ratio
-
0.66
-
Number of buys
-
193
-
Number of sells
-
-174
-
Price
-
$54.18
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2024
495 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q2 2024.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 341 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 136M shares
.
Largest 10 shareholders include BlackRock Inc. (14.7M shares), FMR LLC (11.5M shares), VANGUARD GROUP INC (11.4M shares), T. Rowe Price Investment Management, Inc. (8.14M shares), WELLINGTON MANAGEMENT GROUP LLP (7.51M shares), STATE STREET CORP (6.55M shares), Darwin Global Management, Ltd. (4.58M shares), BANK OF AMERICA CORP /DE/ (4.38M shares), GEODE CAPITAL MANAGEMENT, LLC (2.74M shares), and RTW INVESTMENTS, LP (2.72M shares).
This table shows the top 341 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.